Breit TM - Search Results

1

Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.

van Dongen JJ, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. van Dongen JJ, et al. Among authors: breit tm. Leukemia. 1992;6 Suppl 1:47-59. Leukemia. 1992. PMID: 1548936 Review.

2

Polyclonal expansion of T-cell receptor-gamma delta+ T lymphocytes associated with neutropenia and thrombocytopenia.

van Oostveen JW, Breit TM, de Wolf JT, Brandt RM, Smit JW, van Dongen JJ, Borst J, Melief CJ. van Oostveen JW, et al. Among authors: breit tm. Leukemia. 1992 May;6(5):410-8. Leukemia. 1992. PMID: 1534390

3

Limited combinatorial repertoire of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias.

Breit TM, Wolvers-Tettero IL, Hählen K, van Wering ER, van Dongen JJ. Breit TM, et al. Leukemia. 1991 Feb;5(2):116-24. Leukemia. 1991. PMID: 1826936

4

Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.

Breit TM, Wolvers-Tettero IL, Hählen K, van Wering ER, van Dongen JJ. Breit TM, et al. Leukemia. 1991 Dec;5(12):1076-86. Leukemia. 1991. PMID: 1837811

5

Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results.

Beishuizen A, Verhoeven MA, Mol EJ, Breit TM, Wolvers-Tettero IL, van Dongen JJ. Beishuizen A, et al. Among authors: breit tm. Leukemia. 1993 Dec;7(12):2045-53. Leukemia. 1993. PMID: 7902888

6

Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

van Dongen JJ, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. van Dongen JJ, et al. Among authors: breit tm. Recent Results Cancer Res. 1993;131:157-84. doi: 10.1007/978-3-642-84895-7_15. Recent Results Cancer Res. 1993. PMID: 8210636 Review. No abstract available.

7

tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.

Breit TM, Beishuizen A, Ludwig WD, Mol EJ, Adriaansen HJ, van Wering ER, van Dongen JJ. Breit TM, et al. Leukemia. 1993 Dec;7(12):2004-11. Leukemia. 1993. PMID: 8255100

8

Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease.

Beishuizen A, de Bruijn MA, Pongers-Willemse MJ, Verhoeven MA, van Wering ER, Hählen K, Breit TM, de Bruin-Versteeg S, Hooijkaas H, van Dongen JJ. Beishuizen A, et al. Among authors: breit tm. Leukemia. 1997 Dec;11(12):2200-7. doi: 10.1038/sj.leu.2400904. Leukemia. 1997. PMID: 9447841

9

Receptor diversity of human T-cell receptor gamma delta expressing cells.

Breit TM, Wolvers-Tettero IL, van Dongen JJ. Breit TM, et al. Prog Histochem Cytochem. 1992;26(1-4):182-93. doi: 10.1016/s0079-6336(11)80094-x. Prog Histochem Cytochem. 1992. PMID: 1336611 Review. No abstract available.

10

Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.

Breit TM, Wolvers-Tettero LM, Hählen K, van Wering ER, van Dongen JJ. Breit TM, et al. Leukemia. 1992 Feb;6(2):169-70. Leukemia. 1992. PMID: 1532434 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters